Blog Posts

THEY SAID IT! PRESIDENT TRUMP CALLS OUT BIG PHARMA’S EGREGIOUS PRICING FOR DIABETES AND WEIGHT LOSS DRUGS IN U.S. MARKET

Feb 19, 2025

Brand Name Manufacturers’ Prices for Blockbuster GLP-1 Medications Are Read More

CSRXP STATEMENT ON CONFIRMATION OF RFK JR AS SECRETARY OF U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES

Feb 13, 2025

Campaign Looks Forward to Working with Kennedy and the Administration to Lower Read More

BIG PHARMA EARNINGS WATCH: GILEAD

Feb 13, 2025

Brand Name Drug Company Known for Egregious Product-Hopping Strategy Beats Read More

BIG PHARMA EARNINGS WATCH: ASTRAZENECA, BRISTOL MYERS SQUIBB AND ELI LILLY

Feb 12, 2025

Eli Lilly Signals Plan to Maintain Unsustainably High Prices on Blockbuster Read More

BIG PHARMA EARNINGS WATCH: MERCK AND PFIZER

Feb 7, 2025

Pharmaceutical Giants Continue to Outperform Wall Street Projections While Read More

BIG PHARMA EARNINGS WATCH: AMGEN, GSK AND NOVO NORDISK

Feb 7, 2025

Major Pharmaceutical Companies Continue Growing Revenues While Sticking With Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, NOVARTIS AND ROCHE

Feb 6, 2025

Big Pharma Giants Report Higher-Than-Expected Q4 Earnings Amid Continued Price Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Jan 30, 2025

Johnson & Johnson Beats Wall Street Analysts’ Expectations Fueled by Read More

BIG PHARMA WATCH: MERCK EXPEDITES ANTI-COMPETITIVE STRATEGY ON BLOCKBUSTER CANCER DRUG

Jan 27, 2025

Big Pharma Giant’s Patent Abuse Scheme for Keytruda Will Extend Monopoly Read More

ICYMI: INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW ANNOUNCES ANNUAL LAUNCH PRICE AND ACCESS REPORT FOR 2025

Jan 22, 2025

New Analysis Will Help Shine a Light on Big Pharma’s Increasingly Read More

DOSE OF REALITY: BIG PHARMA WELCOMES 2025 WITH PRICE HIKES

Jan 7, 2025

Brand Name Drug Companies Increase Prices By More Than Rate of Inflation in Read More